mirxes
MiRXES Launches New Manufacturing and Research Capabilities
With a slew of new capabilities and a collaborative project, biotechnology company, MiRXES, hopes to contribute to Singapore’s vision of early cancer screening.
Asia’s Scientific Trailblazers: Cheng He
Recognizing the importance of microRNA as a key biomarker in several diseases, Professor Cheng He hopes to address critical challenges in the development of early disease diagnostic tools at MiRXES.
Five Receive 2021 President’s Science And Technology Awards In Singapore
Singapore has recognized five researchers with the 2021 President’s Science and Technology Awards for pushing the country's frontiers in biomedicine and engineering.
Facing The Double Threat With Fortitude
By differentiating between the two diseases, MiRXES’ new Fortitude SARS-CoV-2 and flu A/B test could help countries face the ‘twindemic’ of flu and COVID-19.
Profiling A Panorama Of Pathologies
By targeting nearly 400 miRNAs linked to over 20 different diseases with a single product, MiRXES’ ID3EAL PanoramiR microRNA knowledge panel proves that it’s possible to achieve more with less.
